MAPK3 and neoplasm: Upregulation of the ERK1/2 gene has been reported to be closely related to chemotherapy resistance, and inhibition of the ERK1/2 gene has been shown to increase the sensitivity of tumor cells to chemotherapeutic agents (20,21).